Skip to Content

DA-032 15 (Abilify MyCite 15 mg)

Generic Name: aripiprazole

Pill with imprint DA-032 15 is Yellow, Round and has been identified as Abilify MyCite 15 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.

Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DA-032 15

Abilify mycite 15 mg DA-032 15

Abilify MyCite

Generic Name
aripiprazole
Imprint
DA-032 15
Strength
15 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Otsuka Pharmaceutical Co., Ltd
National Drug Code (NDC)
59148-0032
Inactive Ingredients
corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide yellow, ferric oxide red, FD&C Blue No. 2, aluminum oxide, aluminum, magnesium, silicon, silicon dioxide, titanium, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.